Key facts
- Rhovica Neuroimaging’s last known valuation is $4.7M (Jul 2025).
- It has raised $3.0M; the latest was Seed Round ($2.9M) in Jul 2025.
- Notable investors include Venture Kick, Kickfund, M2Care, Sitem Startup Club, Valuemaker — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Rhovica Neuroimaging
- ·The full record, as it builds
Funding rounds
No funding rounds for Rhovica Neuroimaging are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rhovica Neuroimaging
Developer of a neuroimaging technology intended to optimize emergency treatment for patients with elevated intracranial pressure. The company's device facilitates the precise and rapid placement of external ventricular drains and provides real-time monitoring post-insertion, enabling medical professionals to improve patient outcomes, reduce procedural complications, and potentially reduce healthcare costs by streamlining critical neurological interventions.
- Sector
- Healthcare
- HQ
- Bern, Switzerland
- Founded
- 2021
- Website
- rhovica.com/
- Ownership
- Privately Held (backing)
Rhovica Neuroimaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rhovica Neuroimaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rhovica Neuroimaging in its N-PORT filings yet. We sweep new filings monthly.